Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02086188
What this trial is testing

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Theodore R. Brown, MD MPH 28
Not applicableStudy completedNCT01080573
What this trial is testing

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 1,257
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06961383
What this trial is testing

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
NeuroGenesis Ltd. 45
Not applicableStudy completedNCT01080027
What this trial is testing

Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 254
Not applicableLooking for participantsNCT04573673
What this trial is testing

Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.

Who this might be right for
Multiple SclerosisLower Urinary Tract Symptoms
University Hospital, Lille 68
Not applicableStudy completedNCT07263854
What this trial is testing

Effects of Lower Extremity Neuromuscular Facilitation and Patients With Multiple Sclerosis

Who this might be right for
Gait BalanceBalanceFatigue Syndrome, Chronic
Sanko University 26
Early research (Phase 1)Study completedNCT00852722
What this trial is testing

Low Fat Diet and Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Oregon Health and Science University 61
Not applicableStudy completedNCT03744351
What this trial is testing

B Cell Differentiation in MS

Who this might be right for
Multiple Sclerosis
Rennes University Hospital 136
Not applicableStudy completedNCT04441229
What this trial is testing

Mobile Attentional Bias Modification Training in Pediatric MS

Who this might be right for
Pediatric Multiple Sclerosis
NYU Langone Health 37
Not applicableStudy completedNCT04754542
What this trial is testing

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

Who this might be right for
Multiple Sclerosis
University of Colorado, Denver 76
Not applicableNot Yet RecruitingNCT07555379
What this trial is testing

Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Sharjah 40
Not applicableStudy completedNCT01207648
What this trial is testing

Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)

Who this might be right for
Multiple Sclerosis
EMD Serono 307
Not applicableStudy completedNCT05437276
What this trial is testing

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)

Who this might be right for
Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
Helius Medical Inc 43
Large-scale testing (Phase 3)Active Not RecruitingNCT05123703
What this trial is testing

Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 188
Testing effectiveness (Phase 2)Study completedNCT00694941
What this trial is testing

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Ono Pharmaceutical Co., Ltd. 15
Large-scale testing (Phase 3)Ended earlyNCT01647880
What this trial is testing

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 15
Not applicableStudy completedNCT03060759
What this trial is testing

Light Therapy as Treatment for Fatigue in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Massachusetts General Hospital 35
Large-scale testing (Phase 3)Study completedNCT00869986
What this trial is testing

Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Eli Lilly and Company 218
Early research (Phase 1)UnknownNCT02365259
What this trial is testing

Phototherapy in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Illinois at Urbana-Champaign 20
Not applicableStudy completedNCT05266469
What this trial is testing

Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 168
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation